Adicet Bio (ACET) News Today → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free ACET Stock Alerts $2.00 +0.05 (+2.56%) (As of 04/22/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAdicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meetingbusinesswire.com - April 22 at 4:30 PMAdicet Bio, Inc. (NASDAQ:ACET) Given Consensus Rating of "Moderate Buy" by Analystsamericanbankingnews.com - April 22 at 2:14 AMAdicet Bio, Inc. (NASDAQ:ACET) Short Interest Updateamericanbankingnews.com - April 14 at 3:12 AMACET Adicet Bio, Inc.seekingalpha.com - April 10 at 7:48 AMAdicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual Conferencebusinesswire.com - April 8 at 7:00 AMAdicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)businesswire.com - March 28 at 5:19 PMThe Penny Stock A-List: 7 High-Profile Companies on the Verge of Greatnessinvestorplace.com - March 28 at 2:28 PMQ1 2024 Earnings Forecast for Adicet Bio, Inc. Issued By HC Wainwright (NASDAQ:ACET)marketbeat.com - March 22 at 7:50 AMAdicet Bio Inc (ACET) Reports Q4 and Full Year 2023 Financial Resultsfinance.yahoo.com - March 21 at 9:51 AMAre Investors Undervaluing Adicet Bio, Inc. (NASDAQ:ACET) By 41%?finance.yahoo.com - March 21 at 9:51 AMAdicet Bio’s Promising Drug Pipeline and Buy Rating Justificationmarkets.businessinsider.com - March 21 at 4:50 AMBuy Recommendation for Adicet Bio Amid Promising Autoimmune and Cancer Therapy Developmentsmarkets.businessinsider.com - March 20 at 6:49 PMBuy Rating Affirmed for Adicet Bio Amid Promising CAR T-Cell Therapies and Strong Financial Footingmarkets.businessinsider.com - March 20 at 6:49 PMAdicet Bio's (ACET) Buy Rating Reaffirmed at HC Wainwrightmarketbeat.com - March 20 at 12:32 PMAdicet Bio (NASDAQ:ACET) Releases Quarterly Earnings Results, Beats Expectations By $0.03 EPSmarketbeat.com - March 20 at 8:47 AMJMP Securities Keeps Their Hold Rating on Adicet Bio (ACET)markets.businessinsider.com - March 20 at 4:44 AMACET Stock Earnings: Adicet Bio Meets EPS for Q4 2023investorplace.com - March 19 at 9:53 PMAdicet Bio: Q4 Earnings Insightsbenzinga.com - March 19 at 6:42 PMAdicet Bio, Inc Q4 loss drops in line with estimatesmarkets.businessinsider.com - March 19 at 6:42 PMAdicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progressbusinesswire.com - March 19 at 4:10 PMAdicet Bio (ACET) Set to Announce Quarterly Earnings on Wednesdaymarketbeat.com - March 12 at 7:35 AMAdicet Bio to Participate in a Fireside Chat at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conferencebusinesswire.com - March 11 at 7:00 AM3 High-Risk Stocks That Could Pay Off in the Millionsinvestorplace.com - March 5 at 11:25 AMAcadian Asset Management LLC Has $715,000 Position in Adicet Bio, Inc. (NASDAQ:ACET)marketbeat.com - March 1 at 5:22 AMAdicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)businesswire.com - February 29 at 7:46 PM7 Top-Tier Penny Stocks for a Smart Betinvestorplace.com - February 27 at 6:53 AM7 Biotech Penny Stocks on the Verge of Clinical Trial Victoryinvestorplace.com - February 25 at 1:37 PMAdicet Bio (NASDAQ:ACET) Share Price Passes Above Two Hundred Day Moving Average of $1.87marketbeat.com - February 23 at 4:34 AMACET Apr 2024 7.500 callfinance.yahoo.com - February 19 at 3:09 PMAdicet Bio, Inc. (NASDAQ:ACET) Sees Large Increase in Short Interestmarketbeat.com - February 14 at 3:58 AMJones upgrades Adicet to buy, cites upcoming catalystsmsn.com - February 13 at 7:09 PMAdicet Bio, Inc. to Post Q1 2024 Earnings of ($0.28) Per Share, Wedbush Forecasts (NASDAQ:ACET)marketbeat.com - February 7 at 8:07 AMAdicet Bio, Inc. (NASDAQ:ACET) Given Average Rating of "Moderate Buy" by Analystsmarketbeat.com - February 7 at 2:30 AMAdicet Bio to Participate in a Fireside Chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conferencefinance.yahoo.com - February 5 at 7:47 PMHC Wainwright Trims Adicet Bio (NASDAQ:ACET) Target Price to $10.00marketbeat.com - February 2 at 10:55 AMAdicet Bio, Inc. (NASDAQ:ACET) Director Acquires $7,500,000.00 in Stockmarketbeat.com - January 26 at 9:24 PMAdicet Bio, Inc. Announces Closing of $98 Million Public Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Sharesfinance.yahoo.com - January 25 at 8:27 PMAdicet Bio, Inc. Announces Pricing of Public Offeringfinance.yahoo.com - January 23 at 8:41 AMAdicet Bio Commences Underwritten Public Offering Of Common Stockmarkets.businessinsider.com - January 22 at 11:27 PMAdicet Bio, Inc. Announces Proposed Public Offeringfinance.yahoo.com - January 22 at 6:27 PMAdicet Bio (NASDAQ:ACET) Upgraded at StockNews.commarketbeat.com - January 9 at 10:16 PMAdicet Bio, Inc. (ACET) Upgraded to Buy: Here's Whymsn.com - January 9 at 6:38 PMAdicet Bio: Clinical Updates In 2H 2024 Makes This A Must-Watchseekingalpha.com - January 9 at 12:57 AMGreat week for Adicet Bio, Inc. (NASDAQ:ACET) institutional investors after losing 71% over the previous yearfinance.yahoo.com - January 7 at 1:05 PMACET Apr 2024 2.500 callca.finance.yahoo.com - January 5 at 12:17 AMAdicet Bio stock rallies 26% on pipeline, cash runway updatesmsn.com - January 4 at 2:16 PMAdicet Provides Corporate Update and Highlights Strategic Priorities for 2024finance.yahoo.com - January 4 at 9:15 AMAdicet Bio to Host Conference Call to Provide Updates on its Clinical Pipeline and Corporate Outlookbusinesswire.com - January 3 at 4:03 PMAdicet Bio Inc Ordinary Sharesmorningstar.com - December 7 at 10:16 PMAnalysts Have Conflicting Sentiments on These Healthcare Companies: Terns Pharmaceuticals (TERN) and Adicet Bio (ACET)markets.businessinsider.com - November 16 at 1:51 AM Get Adicet Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ACET and its competitors with MarketBeat's FREE daily newsletter. Email Address Incredible Opportunity to Retire FAST! (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market. Click here to get instant access to the guide ACET Media Mentions By Week ACET Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACET News Sentiment▼1.020.47▲Average Medical News Sentiment ACET News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACET Articles This Week▼21▲ACET Articles Average Week Get Adicet Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ACET and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: VERU News TRVI News IVA News GOSS News GLSI News CAPR News ALIM News ME News SCPH News RGLS News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ACET) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adicet Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
